Clinical trial, blinded, parallel group study to analyze differences in the safety of roflumilast administered once daily on alternate days for two weeks before the regular schedule once a day. [Ensayo clínico, ciego y de grupos paralelos para analizar diferencias en la seguridad de roflumilast administrado una vez al día en días alternos durante dos semanas respecto a la pauta habitual una vez al día]
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2015
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions; Therapeutic Use
- 07 Jul 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Nov 2013 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 08 May 2013 Planned end date changed from 29 Aug 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.